Gyrodyne (NASDAQ:GYRO) Stock Price Crosses Below Two Hundred Day Moving Average – Here’s Why

Gyrodyne , LLC (NASDAQ:GYRO)’s share price crossed below its two hundred day moving average during trading on Monday . The stock has a two hundred day moving average of $8.71 and traded as low as $7.31. Gyrodyne shares last traded at $7.5180, with a volume of 295 shares traded.

Gyrodyne Price Performance

The company’s 50 day moving average is $7.81 and its 200-day moving average is $8.71.

Institutional Trading of Gyrodyne

A number of institutional investors and hedge funds have recently bought and sold shares of GYRO. Teton Advisors LLC bought a new stake in Gyrodyne during the 3rd quarter valued at about $177,000. Bulldog Investors LLP bought a new stake in Gyrodyne during the 3rd quarter valued at about $601,000. Susquehanna International Group LLP bought a new stake in Gyrodyne during the 3rd quarter valued at about $142,000. Finally, Advisory Services Network LLC bought a new stake in Gyrodyne during the 3rd quarter valued at about $77,000. 71.36% of the stock is currently owned by institutional investors.

Gyrodyne Company Profile

Gyrodyne Company of America, Inc is a New York–based real estate investment and development firm specializing in medical office buildings and professional facilities. Listed on the NASDAQ under the ticker GYRO, the company’s principal business activity is the ownership, leasing and management of commercial properties tailored to healthcare and life sciences tenants. By focusing on outpatient diagnostic and treatment centers, clinical laboratories and related professional suites, Gyrodyne generates steady rental income and seeks to provide purpose-built environments that meet the specific needs of medical practitioners and research organizations.

The company’s core property portfolio is anchored by an approximately 87-acre campus situated in Stony Brook, Long Island.